BioCardia Shares Drop After Public Offering and FDA Clearance
BioCardia shares drop 10% after public offering: California-based BioCardia priced a public offering for $7.2 million to fund working...
Morph DNA Steerable Introducer
FDA Approves BioCardia’s Morph DNA Steerable Introducer: Shares Surge More Than Double
In after-hours trading, BioCardia's shares more than doubled following FDA clearance for their Morph DNA Steerable Introducer product family,...